Delivery Order SPE2DR25D3012-SPE2DR26F4D5V
Award Date 12/16/25
Potential Completion Date 1/8/26
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $7,693.53 to AmerisourceBergen Drug Corp for ProQuad vials on December 9, 2025, with a completion date of December 31, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine providing immunization against measles, mumps, rubella, and varicella, supporting the military...
- The Defense Logistics Agency awarded a $17,711.36 delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of August 25, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine providing immunization against measles, mumps, rubella, and varicella, representing a critical pharmaceutical commodity within the federal medical supply chain. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $16,346.20 to AmerisourceBergen Drug Corp for ProQuad vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 23, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine protecting against measles, mumps, rubella, and varicella, representing a critical pharmaceutical commodity for military and federal healthcare...
- The Defense Logistics Agency awarded a $13,367.20 delivery order to AmerisourceBergen Drug Corp for ProQuad vials on September 16, 2025, with an ultimate completion date of October 7, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, representing a...
- The Defense Logistics Agency awarded a $11,330.27 delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with a completion date of December 22, 2025. This is a firm fixed-price, non-set-aside contract issued on December 1, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. ProQuad is a combination vaccine indicated for prevention of measles, mumps, rubella, and varicella, making this order part of the federal medical supply chain...
- The Defense Logistics Agency awarded a delivery order valued at $13,499.84 to AmerisourceBergen Drug Corp for ProQuad vials on August 25, 2025, with completion targeted for September 16, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine providing immunity against measles, mumps, rubella, and varicella, making this order part of the federal...
- The Defense Logistics Agency awarded a delivery order valued at $3,341.80 to AmerisourceBergen Drug Corp for ProQuad vials on August 15, 2025, with an ultimate completion date of September 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine used to immunize against measles, mumps, rubella, and varicella, representing...
- The Defense Logistics Agency awarded a $49,629.90 firm fixed price delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of August 25, 2025. This is a competitively awarded, non-set-aside contract performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, representing a critical pharmaceutical commodity for military and...
- The Defense Logistics Agency awarded a delivery order valued at $1,670.91 to AmerisourceBergen Drug Corp for ProQuad vials on October 29, 2025, with completion scheduled by November 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine for measles, mumps, rubella, and varicella, supporting the federal government's immunization and...
- The Defense Logistics Agency awarded a delivery order valued at $4,813.98 to AmerisourceBergen Drug Corp for ProQuad vials on December 16, 2025, with a completion date of January 8, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine used to provide immunity against measles, mumps, rubella, and varicella, representing a...